442 related articles for article (PubMed ID: 20085453)
1. Case-based experience in the use of 5-fluorouracil cream 0.5% as monotherapy and in conjunction with glycolic acid peels for the treatment of actinic keratosis.
Goldberg DJ
J Cosmet Laser Ther; 2010 Feb; 12(1):42-6. PubMed ID: 20085453
[TBL] [Abstract][Full Text] [Related]
2. Five percent 5-fluorouracil in a cream or for superficial peels in the treatment of advanced photoaging of the forearms: a randomized comparative study.
Guimarães CO; Miot HA; Bagatin E
Dermatol Surg; 2014 Jun; 40(6):610-7. PubMed ID: 24852464
[TBL] [Abstract][Full Text] [Related]
3. The use of fluor-hydroxy pulse peel in actinic porokeratosis.
Teixeira SP; de Nascimento MM; Bagatin E; Hassun KM; Talarico S; Michalany N
Dermatol Surg; 2005 Sep; 31(9 Pt 1):1145-8. PubMed ID: 16164867
[TBL] [Abstract][Full Text] [Related]
4. 5-Fluorouracil superficial peel for multiple actinic keratoses.
Bagatin E; Teixeira SP; Hassun KM; Pereira T; Michalany NS; Talarico S
Int J Dermatol; 2009 Aug; 48(8):902-7. PubMed ID: 19659874
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain.
Nieves D; Puig-Peiró R; Ferrándiz C; Plazas MJ; Brosa M
Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):539-43. PubMed ID: 25495775
[TBL] [Abstract][Full Text] [Related]
6. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.
Couch SM; Custer PL
Ophthalmic Plast Reconstr Surg; 2012; 28(3):181-3. PubMed ID: 22460673
[TBL] [Abstract][Full Text] [Related]
7. Actinic keratosis. Current treatment options.
Jeffes EW; Tang EH
Am J Clin Dermatol; 2000; 1(3):167-79. PubMed ID: 11702298
[TBL] [Abstract][Full Text] [Related]
8. Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment.
Kaur RR; Alikhan A; Maibach HI
J Dermatolog Treat; 2010 Sep; 21(5):267-71. PubMed ID: 19878034
[TBL] [Abstract][Full Text] [Related]
9. Prospective, case-based assessment of sequential therapy with topical Fluorouracil cream 0.5% and ALA-PDT for the treatment of actinic keratosis.
Martin G
J Drugs Dermatol; 2011 Apr; 10(4):372-8. PubMed ID: 21455547
[TBL] [Abstract][Full Text] [Related]
10. Treatment-refractory actinic keratoses successfully treated using simultaneous combination topical 5-fluorouracil cream and imiquimod cream: a case-control study.
Ondo AL; Padilla RS; Miedler JD; Cockerell CJ; Kerner JD; Steiner RL; Mings SM; Shanler SD
Dermatol Surg; 2012 Sep; 38(9):1469-76. PubMed ID: 22712515
[TBL] [Abstract][Full Text] [Related]
11. Topical fluorouracil for actinic keratoses and photoaging: a clinical and molecular analysis.
Sachs DL; Kang S; Hammerberg C; Helfrich Y; Karimipour D; Orringer J; Johnson T; Hamilton TA; Fisher G; Voorhees JJ
Arch Dermatol; 2009 Jun; 145(6):659-66. PubMed ID: 19528421
[TBL] [Abstract][Full Text] [Related]
12. The new fluor-hydroxy pulse peel. A combination of 5-fluorouracil and glycolic acid.
Marrero GM; Katz BE
Dermatol Surg; 1998 Sep; 24(9):973-8. PubMed ID: 9754085
[TBL] [Abstract][Full Text] [Related]
13. Practice trends in the treatment of actinic keratosis in the United States: 0.5% fluorouracil and combination cryotherapy plus fluorouracil are underused despite evidence of benefit.
Hagele TJ; Levender MM; Davis SA; Williford PM; Feldman SR
J Cutan Med Surg; 2012; 16(2):107-14. PubMed ID: 22513063
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents.
Samrao A; Cockerell CJ
Am J Clin Dermatol; 2013 Aug; 14(4):273-7. PubMed ID: 23640424
[TBL] [Abstract][Full Text] [Related]
15. Noninflammatory destruction of actinic keratoses by fluorouracil.
Breza T; Taylor R; Eaglstein WH
Arch Dermatol; 1976 Sep; 112(9):1256-8. PubMed ID: 999302
[TBL] [Abstract][Full Text] [Related]
16. Clinical Response to Ingenol Mebutate in Patients With Actinic Keratoses.
Batalla A; Flórez Á; Feal C; Peón G; Abalde MT; Salgado-Boquete L; de la Torre C
Actas Dermosifiliogr; 2015 Dec; 106(10):e55-61. PubMed ID: 26055975
[TBL] [Abstract][Full Text] [Related]
17. Case-based considerations in the treatment of actinic keratoses: utilizing combination or sequential therapy with 5-fluorouracil cream and destructive treatments.
Han A; Penrose C; Goldsmith A; Marmur ES
J Drugs Dermatol; 2010 Jul; 9(7):864-9. PubMed ID: 20677546
[TBL] [Abstract][Full Text] [Related]
18. Low-Dose 0.5% 5-Fluorouracil/10% Salicylic Acid Topical Solution in the Treatment of Actinic Keratoses.
Herranz P; Morton C; Dirschka T; Azeredo RR; Roldán-Marín R
J Cutan Med Surg; 2016 Nov; 20(6):555-561. PubMed ID: 27443886
[TBL] [Abstract][Full Text] [Related]
19. Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis.
Stockfleth E; Bégeault N; Delarue A
Dermatol Ther (Heidelb); 2022 Feb; 12(2):467-479. PubMed ID: 34954811
[TBL] [Abstract][Full Text] [Related]
20. In vivo Confocal Laser Microscopy for monitoring of actinic keratosis treatment: a comparison with histopathologic assessment after treatment with topical 5% 5-fluorouracil.
Ishioka P; Maia M; Rodrigues SB; Lellis RF; Hirata SH
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1155-1163. PubMed ID: 29178474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
